Phosphorylation
of the rat brain ryanodine receptor was studied using a monoclonal antibody, Ry-1, against the cardiac ryanodine receptor. A large polypeptide with the same SDS-PAGE mobility as that of the canine cardiac receptor was detected in rat brain membranes by immunoblotting. The brain ryanodine receptor was solubilized from the microsomal membranes with 3-[(3-cholamidopropyI)dimethylammoniol-1 -propanesulfonicacid (CHAPS), and more than 85% of the solubilized receptor was immunoprecipjtated by Ry-1. lmmunoprecipitated receptors were phosphorylated by CAMP-dependent protein kinase. The ryanodine receptor was also expressed in cultured fetal rat brain neurons and was phosphorylated by treating the cells with dibutyryl CAMP.
The number of cells showing a caffeine-induced
Caz+ transient was increased significantly in the phosphorylating condition. These results suggest that the Ca channel activity of the brain ryanodine receptor is regulated by CAMP-dependent phosphorylation.
Control of the cytoplasmic free CaZ+ level is quite important in the regulation of various neuronal functions, such as membrane excitability, neurotransmitter release, protein phosphorylation and dephosphorylation, and gene expression (for reviews, see Kennedy, 1989) . In various kinds of cells including neurons, the release of Ca2+ from intracellular Ca2+ storage sites plays a crucial role in the regulation of cytoplasmic Ca*+ levels (Lipscombe et al., 1988a; Thayer et al., 1988) . The Ca2+/caffeinesensitive Ca channel provides one of the pathways for the release of Cal+ from its storage sites (Kuba, 1980; Neering and McBurney, 1984; Lipscombe et al., 1988b; Thayer et al., 1988; Wakade et al., 1990) . This type of Ca channel has been purified as the receptor of a plant alkaloid, ryanodine, from both skeletal Inui et al., 1987a; Lai et al., 1988b) and cardiac muscle (Inui et al., 1987b; Lai et al., 1988a) . Cloning and sequence analysis of the cDNAs encoding these receptors have revealed that they are distinct gene products Nakai et al., 1990; Otsu et al., 1990) . The ryanodine receptor is also found in brain microsomal membranes (Ashley, 1989 ) and the receptor protein has recently been identified using polyclonal and monoclonal antibodies raised against the skeletal muscle receptor (Ellisman et al., 1990; McPherson and Campbell, 1990) .
The functioning of ion channels is regulated by various protein kinases (Rossie and Catterall, 1987) and it is believed that such regulation is one of the important mechanisms underlying the plasticity of neuronal systems. It has been reported that the cardiac ryanodine receptor is phosphorylated by CAMP-dependent, cGMP-dependent, CaZ+/phospholipid-dependent, and Ca*+/calmodulin-dependent protein kinases (Takasago et al., 1989, 199 1) . However, phosphorylation of the brain ryanodine receptor has not been studied so far. In the present series of experiments, we isolated the brain ryanodine receptor with a monoclonal antibody recognizing the cardiac receptor and found that it could be phosphorylated by CAMP-dependent protein kinase both in a cell-free system and in cultures of central neurons. In addition, the caffeine-induced rise in cytoplasmic CaZ+ levels in cultured neurons was found to be enhanced in the phosphorylating condition.
Materials and Methods
Materials. A monoclonal antibody, Ry-1, was prepared as described previously . The catalytic subunit of type I CAMPdependent protein kinase was purchased from Sigma. Bovine lung cGMPdependent protein kinase, rat brain Ca*+/phospholipid-dependent protein kinase, and rat brain CaZ+/calmodulin-dependent protein kinase II were kindly provided by Dr. Ken-ichi Furukawa (Tohoku University), Dr. Tokiko Hama-Mizuochi (Mitsubishi Kasei Institute of Life Sciences), and Dr. Eishichi Miyamoto (Kumamoto University), respectively. The sources ofthe other drugs and chemicals used wereas follows: jH-rvanodine and Y-~~P-ATP. New Enaland Nuclear: 9.2 1 -didehvdrorvanodine, Wako Pure Chemical Indust>es; affinity-purified mouse IgG, Zymed Laboratories; protein A-Sepharose, Pharmacia LKB Biotechnology; papain, Worthington Biochemical Corp.; fura-acetoxymethylester, Dojin; ECL gene detection reagent, Amersham; and all other chemicals, Wako, Sigma, or Bio-Rad Laboratories.
Membrane preparation. Freshly isolated whole rat brains were homogenized in 10 vol of 0.32 M sucrose and 50 mM HEPES-Tris (pH 7.4) containing protease inhibitors (1 mM phenylmethanesulfonyl fluoride, 1 PM pepstatin A, 1 mM l,lO-phenanthroline, 1 &ml antipain, and 1 &ml leupeptin). The membranes were fractionated by successive differential centrifugation at 800 x g for 10 min, at 9,200 x g for 15 min, and at 165,000 x g for 60 min, and the respective precipitates were designated as P,, P,, and P,. The membranes were resuspended in the same solution and stored at -80°C until use. Solubilization of the ryanodine receptor. Membranes were washed once by centrifugation with solution A [ 1 M NaCl, 2 mM dithiothreitol, and 50 mM HEPES-Tris, pH 7.4, with the protease inhibitors]. The precipitates were then solubilized and sonicated in solution B [ 1% 3-[(3-cholamidopropyl) dimethylammonio]-1 -propanesulfonic acid (CHAPS) and 0.5% phosphatidylcholine (PC) in solution A] for 30 min on ice.
After removing the insoluble materials by centrifugation at 540,000 x g for 15 min, the solubilized materials were stored frozen at -80°C. 3H-ryanodine binding assay. Membranes were washed with solution A and incubated in the same solution containing 1 mM EGTA, 1.05 mM CaCi,, and various concentrations of )H-ryanodine for 2 hr at room temperature (22-25"(Z) . Incubation was terminated by filtration through Whatman GF/B filters followed bv raoid washina with solution A. and the bound radioactivity was analyzed-by liquid scintillation spectrometry. For determination of )H-ryanodine binding to solubilized receptors, the solubilized sample was incubated for 2 hr at room temperature with various concentrations of 'H-ryanodine in binding solution (1 mM EGTA and 1.05 mM CaCl, in solution B). The bound radioactivity was detected by polyethylene glycol (PEG) precipitation, as described previously (Takahashi and Fujimoto, 1989) . Specific binding was determined by subtracting the nonspecific binding obtained in the presence of 50 PM 9,2 1 -didehydroryanodine.
Immunoprecipitation of jH-ryanodine binding protein by a monoclonal antibody, Ry-1. Solubilized ryanodine receptors were prelabeled with )H-ryanodine and then incubated with various amounts of either control mouse IgG or a monoclonal antibody, Ry-1, for 2 hr at room temperature. The antigen-antibody complexes were absorbed onto protein A-Sepharose swollen in the binding solution, and washed with the binding solution by centrifugation. Then the radioactivity in the immunoprecipitates was measured with a liquid scintillation counter. The amount of ryanodine receptors remaining in the supematant was determined by the PEG precipitation method as described above.
Immunoblot assay. Proteins were transferred from the polyacrylamide gel to a nitrocellulose sheet as described previously (Takahashi and Catterall, 1987) . After protein transfer, the nitrocellulose paper was incubated in 5% (w/v) nonfat milk and PBS for 2 hr at room temperature, and then with antibody in 5% milk/PBS for 2 hr at room temperature. Blots were washed four times with PBS containing 0.05% Tween-20 and incubated with peroxidase-conjugated goat anti-mouse IgG at 1: 1000 dilution in 5% milk/PBS for 2 hr at room temperature. After being washed a further four times, the sheets were incubated with ECL gene detection reagent and then exposed to Kodak X-OMAT RP film.
Phosphorylation of immunoprecipitated ryanodine receptors. Solubilized brain microsomal proteins were incubated with Ry-1 or control mouse IgG for 2 hr at room temperature, and then the resulting antigenantibody complexes were absorbed onto 3 mg of protein ASepharose swollen in solution B. The complexes were washed three times by centrifugation with the same solution and then three times with 1% CHAPS, 0.5% PC. 6 mM MeCl,. 0.3 mM CaCl,. orotease inhibitors. and 50 mM HEPES-Tris (pH ?.4):'The samples were suspended in lb0 ~1 of the same solution containing 2 MM +rJ*P-ATP (10 j&i) and the following amounts of protein kinase: the catalytic subunit of CAMP-dependent protein kinases, 35.7 U; cGMP-dependent protein kinase, 1.4 pg; Ca2+/ calmodulin-dependent protein kinase II, 0.76 pg; and Ca2+lphospho-lipid-dependent protein kinase, 1.54 pg. After 10 min of incubation at 37°C the reaction was terminated by adding 1 ml of cold NEHDPF solution (1% CHAPS, 0.5% PC, 0.9 M NaCl, 50 mM Na-phosphate, 2.5 mM EDTA, 20 mM NaF, 50 mM HEPES-Tris, pH 7.4, and protease inhibitors). This was immediately followed by washing three times with NEHDPF solution. The phosphorylated proteins in the precipitate were analyzed by SDS-PAGE and a Fuji Bioimage-analyzer BAS 2000 (Fuji Photo Film Co., Tokyo) using an imaging plate (Amemiya and Miyahara, 1988) .
Cell culture. Dissociation cell culture of cortical neurons was performed in the conventional manner. Briefly, cerebral cortices were dissected out from Wistar albino rat embryos at 17-20 d of gestation. Cells were dispersed by papaination (10 U/ml, 37°C) followed by trituration, and then plated on polyethylenimine-coated coverslips (for Ca*+ fluorometry) or plastic dishes (for phosphorylation assay) at a density of 2-5 x 105/cm2. Cultures were maintained for 7-14 d in Dulbecco's modified Eagle's medium supplemented with 5% newborn calf serum and 5% horse serum.
Phosphorylation of cultured brain cell ryanodine receptors. Cells were treated with 2 mM dibutyryl CAMP (dbcAMP) in low-K+ solution (140 mMNaCl,4.7mMKCl, 1.2mMKH,PG,,2.5mMCaCl,, 1.2mMMgSG,, 11 rnr.4 ducose. and 15 mM HEPES-Tris. DH 7.4) for 20 min at 37°C. solubilized in cold NEHDPF, and incubated with either Ry-1 or control mouse IgG for 2 hr at room temperature. The antigen-antibody complex was adsorbed onto protein ASepharose and washed three times by centrifugation with the same solution. The immunoprecipitate was washed three times with 1% CHAPS, 0.5% PC, 6 mM EGTA, 6 mM MgCl,, and 50 mM HEPES-Tris (pH 7.4), and then incubated in the same solution with 2 PM y-3zP-ATP (5 PCi) and the catalytic subunit of CAMP-dependent protein kinase (16 U) for 10 min at 30°C. The reaction was stopped by adding cold NEHDPF, and the phosphorylated proteins in the immunoprecipitate were analyzed by SDS-PAGE and the Fuji Bioimage-analyzer using an imaging plate (Amemiya and Miyahara, 1988) .
In some experiments, cells were washed with phosphate-free low-K+ solution and incubated in 1 ml of the same solution containing 100 r&i of 3zP0, for 18 hr at 37°C. After washing with low-K+ solution, 2 mM dbcAMP was added for 20 min. After solubilizing the cells with NEHDPF, the ryanodine receptors were immunoprecipitated using the Ry-1 monoclonal antibody and the phosphorylated proteins were analyzed as described above.
Ca*+ jluorometvy. Fluorometry for observing changes in [Ca2+], was carried out conventionally (Ogura et al., 1988) . Briefly, the cells were loaded with fura-by exposure to 5 PM fura-acetoxymethylester for 30 min (37°C) and then placed under a Nikon fluorescence microscope equipped with a xenon lamp, interference filters, and a silicon-intensified-target video camera (Hamamatsu Photonics). Digital ratio imaging was performed at two illumination wavelengths (340 and 360 nm) for multiple pixel windows, each ofwhich covered the cell bodies. Drugs (caffeine and dbcAMP) were included in the medium, which was perfused continuously. The neuronal nature of the monitored cells was confirmed by a rapid elevation in [Ca*+] , in response to 50 mM K+ at the end of each experiment. A separate experiment coupled with immunochemical identification of cell types revealed that the rapid high-K+ response was specific to the cells positive in microtubule-associated protein-2 or negative in glial fibrillary acidic protein (A. Ogura and Y. Kudo, unpublished observations). Fluorometty was performed at room temperature.
SDS-polyacrylamide gel electrophoresis. Proteins were separated by SDS-PAGE as described previously (Yoshida et al., 1990) except that a gel with a linear 4-l 2% acrylamide gradient (Tefco) was used.
Results
Immunoblotting of rat brain membranes with a monoclonal antibody, Ry-I In order to study the distribution of the ryanodine receptor in membranes obtained from rat brain homogenate, proteins in the P,, P,, and P, membrane fractions were analyzed by immunoblotting. A monoclonal antibody, Ry-1, raised against canine cardiac tyanodine receptor was used for probing the blots.
Ry-1 has been shown to react with the cardiac muscle ryanodine receptors of various animal species but not with skeletal muscle receptors . As shown in Figure 1 , a large polypeptide having the same mobility as purified canine cardiac ryanodine receptor was detected in all these fractions. No significant staining was observed without Ry-1 (lanes 5-7). The density of the polypeptide, estimated from the intensity of the staining, was highest in the P, membrane fraction, and the band was not detected in the soluble fraction (data not shown).
Distribution and properties of the rat brain ryanodine receptor The 3H-ryanodine binding assay was performed using various membrane fractions of rat brain homogenate. The density of the receptor in the P, membrane fraction was 1.6-2.8 times higher than in the P, and P, fractions (data not shown). Scatchard analysis of 3H-ryanodine binding to the P, membrane fraction yielded a straight line with apparent B,,, and Kd values of 586 fmol/mg protein and 1.2 nM, respectively (Fig. 24 . The Kd value was in good agreement with those obtained by Ashley (1989) in brain microsomal membranes (B,,, = 590 fmol/mg; Kd = 2.7 nM) and by McPherson and Campbell (1990) ryanodine binding (1.5 nM) did not change significantly after the solubilization, but the B,,, was decreased to 150 fmol/mg protein (Fig. 2B) .
Immunoprecipitation of the solubilized rat brain ryanodine receptor with a monoclonal antibody, Ry-1 The rat brain ryanodine receptors were solubilized from the microsomal membranes, labeled with )H-ryanodine in the presence or absence of excess unlabeled 9,2 1 -didehydroryanodine (50 PM), and immunoprecipitated by either Ry-1 or control mouse IgG. As shown in Figure 3 , the specific binding sites in the immunoprecipitate increased with an increase in the amount of antibody added. A concomitant decrease in the specific binding sites in the supernatant was observed. With the addition of a sufficient amount of IgG, more than 85% of the solubilized binding site was immunoprecipitated by Ry-1. In contrast, the amounts of nonspecific binding sites in both the precipitate and the supematant did not change after immunoprecipitation. Control mouse IgG did not immunoprecipitate the specific binding sites at all concentrations added (data not shown). These results indicate that a large portion of the solubilized rat brain ryanodine receptors were immunologically identical with the cardiac receptor, but distinct from the skeletal muscle receptor, because Ry-1 has been shown to recognize the cardiac receptor specifically . receptor. An aliquot of the rat brain P, membrane fraction (0.1 ml at 2.5 mg protein/ml) (A) and the solubilized proteins (0.14 ml at 1.17 mg protein/ml) (B) were incubated for 2 hr at room temperature with 0.4-16 nM 'H-ryanodine. Total binding was determined as described in Materials and Methods. Nonspecific binding was determined in the presence of 50 PM 9,2 1 -didehydroryanodine. All experiments were performed in triplicate. Scatchard analysis of bound/free (B/F) versus bound radioactivity yielded apparent B,,,,, and Kd values of 0.586 pmol/mg protein and 1.2 nM, respectively, for the P, membrane fraction, and 0.15 pmol/mg and 1.46 nM, respectively, for the solubilized proteins (insets).
high molecular weight polypeptide having the same molecular size as the canine cardiac ryanodine receptor was phosphorylated in the immunoprecipitate produced by Ry-1. This phosphorylated band was not detected in the immunoprecipitate produced by the control mouse IgG (lane I), indicating that the phosphoprotein was the brain ryanodine receptor. The brain ryanodine receptor was also phosphorylated by the cGMP-dependent, Ca2+/phospholipid-dependent, and Ca2+/calmodulin-dependent protein kinases (lanes 3-8) . However, the incorporation of 3zP by Ca2+/phospholipid-dependent and Ca*+/ calmodulin-dependent protein kinase was much less than those by CAMP-dependent and cGMP-dependent protein kinase, at least under the present experimental conditions. Figure 5A , a phosphorylated polypeptide having the same apparent molecular size as the canine cardiac ryanodine receptor was detected only in the immunoprecipitate produced by Ry-1, indicating that ryanodine receptors capable of being phosphorylated by CAMP-dependent protein kinase were expressed by cultured fetal rat brain cells.
The incorporation of 32P into ryanodine receptors in vitro was significanatly reduced (7 1% of control) by pretreating the cells with 2 mM dbcAMP for 20 min prior to solubilization (Fig. 5A,  lanes 3 and 4; B) . A similar reduction of the 3zP incorporation in vitro was also observed in cells pretreated with 2 PM forskolin for 20 min (data not shown). These results suggested that the ryanodine receptor of the cultured brain cells was phosphorylated by endogenous CAMP-dependent protein kinase after treatment with dbcAMP and forskolin. This suggestion was further confirmed by a metabolic labeling experiment in which cultured brain cells were incubated with radioactive inorganic phosphate, 32P0,, for 18 hr. The cells were treated with 2 mM dbcAMP for 20 min and solubilized with CHAPS/PC, and ryanodine receptors were immunoprecipitated by Ry-1. As shown in Figure 6 , incorporation of 3ZP into the ryanodine receptor was increased more than twofold after treatment with dbcAMP.
Effect of CAMP on the ryanodine-sensitive Ca2+ transient Caffeine-induced changes in the intracellular concentration of free Ca2+ ( [Ca"],) in the cultured neuronal cells were monitored by microfluorometry using the Ca*+ indicator dye fura-2. As shown in the left part of Figure 7 , there was a population of (Fig. 7, right) . The criterion for the presence/absence of a response was set as a peak [Ca2+], exceeding 100 nM (1 .O for the F340/F360 fluorescence ratio) after exposure to caffeine (20 mM). A response was present in 24.1 + 5.8% of the cell population (mean + SEM of three independent examinations covering 117 cells) before treatment with dbcAMP (1 mM), and in 35.5 + 6.6% after treatment (three independent examinations covering 135 cells). An equivalent increase in the number of responding cells was reproduced by treatment with forskolin (data not shown). The magnitude of the [CaZ+], rise did not increase significantly in the cells that were responsive before dbcAMP treatment (e.g., cell 5 in Fig.  7) . In a preliminary study, similar sensitization after dbcAMP treatment was also recognized in non-neuronal (high-K+-insensitive) cells (data not shown).
Discussion
Brain ryanodine receptor In the present study, we identified the rat brain ryanodine receptor using a monoclonal antibody raised against purified canine cardiac ryanodine receptor. cDNA cloning analysis has revealed that the ryanodine receptors of cardiac and skeletal muscle are different gene products ; Na- Otsu et al., 1990) . The results obtained in this study clearly showed that the rat brain ryanodine receptor can be distinguished from the skeletal one.
(1) Ry-1, which has no cross-reactivity with the skeletal muscle receptor, could immunoprecipitate more than 85% of the solubilized specific ryanodine binding sites obtained from rat brain (Fig. 3) , indicating that most of the solubilized brain receptor was different from the skeletal muscle receptor. (2) It has been shown by SDS-PAGE that the apparent molecular size of the cardiac receptor was smaller than that of the skeletal muscle receptor . In the present study, we found that the migrating position of the brain ryanodine receptor on SDS-PAGE was the same as that of the cardiac receptor (Fig. 1) . These results are consistent with the results obtained by Northern blot analysis using the cDNAs of the skeletal and cardiac ryanodine receptors as molecular probes, which showed that an mRNA only hy-bridizable with the cardiac probe was primarily expressed in the brain (Nakai et al., 1990; Otsu et al., 1990) . The brain ryanodine receptor has recently been identified using polyclonal and monoclonal antibodies against the skeletal muscle receptor (Ellisman et al., 1990; McPherson and Campbell, 1990 ). However, the apparent molecular sizes of the polypeptides identified in the brain were smaller than that of the skeletal muscle receptor. Since the amino acid sequence of the cardiac ryanodine receptor is 66% identical with that of the skeletal muscle receptor, the antibodies used in these other studies probably recognized structures common to both types of receptor. The partial primary structure of the brain ryanodine receptor has been determined by cDNA analysis and so far appears to be identical with that of the cardiac receptor (Nakai et al., 1990) . It is an important further problem to determine whether the brain ryanodine receptor is actually identical with the cardiac receptor.
Possible functions of the brain ryanodine receptor
The following lines of evidence support the idea that the skeletal muscle and cardiac ryanodine receptors work as CaZ+ release channels for the intracellular Ca2+ storage site: (1) A ryanodinesensitive Cat+ current was observed in a planar lipid bilayer incorporating the ryanodine receptor purified fromcardiac (Lai et al., 1988b; Anderson et al., 1989) and skeletal Hymel et al., 1988; Lai et al., 1988a; Smith et al., 1988) muscle. (2) Ryanodine binding activity and the caffeinesensitive Ca channel were concomitantly expressed by Chinese hamster ovary cells transfected with the cDNA of the skeletal muscle ryanodine receptor (Penner et al., 1989) or in Xenopus oocytes injected with the mRNA encoding the cardiac ryanodine receptor (Nakai et al., 1990) .
It has been shown that caffeine, an activator of the ryanodinesensitive Ca2+ release channel in skeletal and cardiac muscle, causes an increase in [Ca2+li in peripheral neurons (Kuba, 1980; Neering and McBumey, 1984; Lipscombe et al., 1988b; Thayer et al., 1988; Wakade et al., 1990) . In the present study, we showed that caffeine also induced Ca2+ transients in CNS neurons. Ashley (1989) found that the ryanodine-sensitive Ca channel appeared after the incorporation of brain microsomal membranes containing the ryanodine receptor into planar lipid bilayers. In out preliminary study, Ca2+/caffeine-induced Ca2+-releasing activity was also detected in brain microsomal membranes (A. Yoshida and M. Takahashi, unpublished observations) . These results suggest that the brain ryanodine receptor also functions as a Ca2+/caffeine/ryanodine-sensitive Ca2+-releasing channel. However, experiments including purification and reconstitution of the brain ryanodine receptor will be necessary to obtain a final conclusion regarding this hypothesis.
Most of the cells in which a caffeine-induced Ca2+ transient was detected in the present study also showed Ca2+ elevation following K+-mediated depolarization, indicating that the caffeine-sensitive Ca*+ release channel is expressed by some CNS neurons. At the same time, we have to point out that there are a fair number of cells that responded to K+-mediated depolarization but not to caffeine. The nature of these caffeine-insensitive cells is not known at present.
Phosphorylation of the rat brain ryanodine receptor
We showed here for the first time that the rat brain ryanodine receptor could be phosphorylated by either CAMP-, cGMP-, Ca*+/phospholipid-, or Ca2+/calmodulin-dependent protein kinases (Fig. 4) . Furthermore, the ryanodine receptor expressed by living central neurons was strongly phosphorylated by treatment with dbcAMP and forskolin (Figs. 5, 6) , which are known to induce the activation of endogenous CAMP-dependent protein kinase. The skeletal muscle ryanodine receptor has been shown not to be phosphorylated by CAMP-dependent protein kinase , and so the brain receptor can be distinguished from the skeletal one from this point. It is well known that the functions of a variety of ionic channels and receptors in the plasma membrane are regulated through phosphorylation by protein kinases (Rossie and Catterall, 1987) . As for ionic channels in the intracellular membranes, the function of the IP,-sensitive Ca channel has been shown to be suppressed by CAMP-dependent phosphorylation (Supattapone et al., 1988) . The maximal number of binding sites for ryanodine in the cardiac membranes increases after CAMP-dependent phosphorylation (Takasago et al., 1989, 199 1) . Since ryanodine is thought to bind to the receptor only in its open state, these results suggest that the channel-regulating activity of the cardiac ryanodine receptor is regulated by CAMP-dependent phosphorylation. In the present study, we demonstrated that the population of caffeine-sensitive cells was significantly increased by activating intracellular CAMP-dependent protein kinase (Fig.  7) . These results suggest that the Ca channel-regulating activity of the brain ryanodine receptor is mediated by CAMP-dependent phosphorylation as well. However, it is not yet clear whether the phosphorylation modifies either the Ca*+ efflux rate or [Ca*+] , sensitivity of the ryanodine receptor. Further studies, including the purification and reconstitution of the brain ryanodine receptor, are necessary to allow a final conclusion to be reached.
